A project of the Participatory Politics Foundation and the Sunlight Foundation

Register

Login with Facebook

U.S. Congress - S.2236 Advancing Breakthrough Therapies for Patients Act of 2012

A non-profit, non-partisan public resource

Everyone can be an insider. Learn how.

S.2236 - Advancing Breakthrough Therapies for Patients Act of 2012

A bill to provide for the expedited development and evaluation of drugs designated as breakthrough drugs. view all titles (2)

All Bill Titles

Official: A bill to provide for the expedited development and evaluation of drugs designated as breakthrough drugs. as introduced.
Short: Advancing Breakthrough Therapies for Patients Act of 2012 as introduced.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Actions

All Actions

Mar 26th	Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 26th	Introduced in Senate

Vote on This Bill

-% Users Support Bill

0 in favor / 0 opposed

Yes

I Support this Bill

I Oppose this Bill

Send Your Senator a Letter

about this bill Support Oppose Tracking

Track with MyOC

Get Email Alerts

Share This Bill

More

Share

Share via Email

Save to Notebook Make A Bill Widget Send us Feedback

OC Blog Articles Related To This Bill

Recent OC Blog Articles

OpenCongress is a free and open-source project of the Participatory Politics Foundation, a 501(c)3 non-profit organization with a mission to increase civic engagement. The non-profit Sunlight Foundation is the Founding and Primary Supporter of OpenCongress.